Table 3 Demographic, clinical, echocardiographic, and microbiological characteristics in 90 surgical patients affected by IE on native mitral valve treated with valve repair or replacement
From: Feasibility and outcome of mitral valve repair in patients with infective endocarditis
Variable | Repair (n = 33) | Replacement (n = 57) | p value |
|---|---|---|---|
Second valve infection | 12 (36%) | 8 (14%) | 0.014 |
Vegetation length (mm), mean ± SD | 6.99 ± 7.14 | 14.35 ± 6.78 | 0.001 |
Spondylodiscitis, n (%) | 7 (21) | 4 (7) | 0.048 |
Gender (women), n (%) | 6 (18) | 20 (35) | 0.088 |
First episode of IE, n (%) | 33 (100) | 50 (88) | 0.036 |
Age (years), mean ± SD | 63.7 ± 13.1 | 63.6 ± 13.9 | 0.96 |
BMI, mean ± SD | 24.1 ± 4.4 | 25.5 ± 4.5 | 0.33 |
Diabetes, n (%) | 4 (12) | 16 (28) | 0.079 |
Chronic kidney disease, n (%) | 4 (12) | 17 (30) | 0.056 |
Arterial hypertension, n (%) | 13 (39) | 33 (58) | 0.091 |
Previous malignancies, n (%) | 5 (15) | 10 (17) | 0.76 |
Dyslipidemia, n (%) | 7 (23) | 18 (33) | 0.29 |
Pacemaker, n (%) | 1 (3) | 5 (9) | 0.58 |
Drug abuse, n (%) | 3 (9) | 5 (9) | 0.29 |
Paravalvular extension, n (%) | 3 (9) | 7 (12) | 0.63 |
Severe valvular dysfunction, n (%) | 20 (61) | 41 (59) | 0.26 |
LVEF (%), mean ± SD | 58.5 ± 9.0 | 60.0 ± 10.5 | 0.48 |
TAPSE (mm), mean ± SD | 22.3 ± 5.0 | 23.1 ± 6.0 | 0.67 |
EuroScore-II | 9.4 ± 28.8 | 9.8 ± 13.7 | 0.93 |
Early surgery, n (%) | 28 (85) | 42 (74) | 0.22 |
Streptococcus spp./, n (%) | 13 (40) | 15 (26) | 0.19 |
Staphylococcus aureus, n (%) | 6 (18) | 11 (19) | 0.89 |
Negative coagulase staphylococci, n (%) | 2 (6) | 8 (14) | 0.36 |
Enterococci, n (%) | 5 (15) | 6 (10) | 0.51 |
Other, n (%) | 1 (3) | 4 (7) | 0.60 |
Negative cultures, n (%) | 6 (18) | 13 (23) | 0.57 |